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Purpose: Open surgical muscle biopsy (OB) and percutaneous Bergstroem needle muscle biopsy 
(NB) are equally accepted procedures. However, there are no data comparing intraprocedural 
pain for both techniques. We designed this prospective trial to test the hypothesis that the less 
invasive NB causes less intraprocedural pain than OB.
Methods: In a two-center prospective trial, 33 patients underwent both procedures in one 
  session. All patients quantified intraprocedural pain using the numeric rating scale (NRS). 
Mean NRS values were calculated along with the difference in NRS values (∆NRS) between 
both types of biopsies.
Results: Mean NRS values were 4.5 (±2.7 standard deviation [SD]) for NB and 3.2 (±2.1) 
for OB (P=0.02). Of the patients, 57.6% described the ∆NRS as #2 NRS points. Regarding 
the pain categories “mild” (NRS 0–3), “moderate” (NRS 4–7), and “severe” (NRS 8–10), no 
significant difference was observed between NB and OB. Patients who found NB to be more 
uncomfortable were more likely to quantify the ∆NRS as .2 NRS points than patients finding 
OB more uncomfortable.
Conclusion: Our results do not support the hypothesis that intraprocedural pain in NB is less 
than in OB. When informing the patient about both types of muscle biopsies, the amount of 
intraprocedural pain should not serve as a differentiating characteristic.
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Introduction
Muscle biopsies are essential diagnostic procedures for various neurological diseases.1–3 
They are usually conducted using either an open surgical approach or a minimally 
invasive percutaneous needle technique. Ever since Bergstroem first described the 
needle biopsy technique, one of the main controversies regarding this approach was 
that its sample yield might be too small for sufficient diagnostics and that therefore the 
needle technique might not be able to compete with the open biopsy (OB).4 Advocates 
of the percutaneous Bergstroem needle biopsy (NB) technique reacted to this by 
introducing certain technical modifications that were shown to significantly increase 
sample yield.5–7 These advances and the fact that percutaneous techniques produce 
significantly less scarring due to a smaller skin incision prompted many centers to 
abandon the open surgical approach completely.8,9 Another supporting argument for 
percutaneous muscle biopsy techniques is the general assumption that less invasive 
techniques might be less painful for the patient.10,11
However, a factor that has been neglected in the literature is the patient’s actual percep-
tion of pain during a muscle biopsy. Since muscle biopsies are predominantly conducted Journal of Pain Research 2014:7 submit your manuscript | www.dovepress.com
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with only local anesthesia, the patient has to deal with relevant 
side effects of an awake surgical procedure – mainly pain. The 
hypothesis that the NB technique might decrease pain and 
discomfort during muscle biopsy when compared to the open 
approach has never been tested before.
To test this hypothesis we designed a two-center prospec-
tive trial to compare pain sensation in patients undergoing 
both procedures in one surgical session.
Methods
The trial was designed as a two-center prospective study (Ulm 
and Berlin). This pain assessment study was approved by the 
local ethics committee of the Charité in Berlin (EA4/043/13). 
It was conducted as an adjunct to a separate, ongoing study 
of patients with amyotrophic lateral sclerosis who underwent 
both an OB and an NB of the deltoid muscle as part of the 
study protocol of the NOG113531 trial. All patients were 
fully informed about the trial and gave written consent.
Biopsy procedures
In all patients the same deltoid muscle was used for both 
types of biopsies. The patients were informed that after both 
biopsies they would be asked for an assessment of intrapro-
cedural pain. The NB was carried out first and immediately 
followed by the OB. Both sites of biopsy were placed at least 
3 cm apart from each other. All procedures were carried out 
in an operating room.
For the NB, the skin and subcutaneous tissue were infil-
trated with about 2 mL of lidocain (2%) for local anesthesia 
at the site of biopsy, after which 3 minutes was given for the 
lidocain to take effect. Care was taken not to enter the muscle 
tissue, so that the lidocain would have no effect on the numeric 
rating scale (NRS) assessment and the histological read out. 
Next, the skin and the muscle fascia were stab incised with a 
size 11 blade, creating an opening large enough to allow for 
passage of the 5 mm type Bergstroem needle. Then, the needle 
was advanced through the muscle fascia into the muscle at a 
depth of about 1 cm. Next, a 50 mL syringe was connected 
to the suction port of the needle via a 10 cm extension tube. 
To open the cutting port of the needle the trochar was pulled 
out by about 1–2 cm. The surgeon and the assistant then syn-
chronized manual suction (via the syringe) and the closure of 
the needle, so that the muscle parts that were sucked into the 
needle lumen would be cut out. The needle was then removed 
and the muscle sample recovered. Finally, the wound was 
closed using a 3.0 nylon suture.
For the OB, an incision mark of about 3–4 cm was drawn 
onto the skin over the deltoid muscle at least 3 cm distant to 
the site of the NB. Local anesthesia of this area was conducted 
using about 2–5 mL of lidocain (2%) and taking care not to 
enter below the subcutaneous tissue. Again, 3 minutes was 
given for the lidocain to take effect. Next, the skin was incised 
using a size 11 blade and the muscle fascia was visualized 
using blunt preparation. Next, a cube of about 1×1×1 cm3 
was cut out of the muscle using a scalpel or scissors. Excess 
bleeding was addressed with cauterization. Finally, the 
muscle fascia was closed using resorbable sutures and the 
skin was closed using 3.0 nylon sutures.
Wound healing was checked 7–10 days after biopsy, 
followed by removal of the sutures.
Pain assessment
Both biopsies, NB and OB, were conducted consecutively. 
Within the first minute after completion of the skin closure of 
the second biopsy, each patient was asked to rate the amount 
of pain for each biopsy separately on the NRS with values 
from 0–10; “0” represented no pain, “10” maximal pain. NRS 
values were then grouped into the following categories: “mild 
pain” (NRS 0–3), “moderate pain” (NRS 4–7), and “severe 
pain” (NRS 8–10). In accordance with previously published 
data, a difference in NRS (∆NRS) of #2 points was consid-
ered not to be clinically relevant.11 The patient was also asked 
which biopsy procedure he/she found more uncomfortable.
Statistics
All analyses were performed using SPSS software, 
Version 22.0.0.0 (IBM Corporation, Armonk, NY, USA). We 
used the Shapiro–Wilk test to analyze whether data were dis-
tributed normally. Since NRS values were normally distributed, 
the paired samples t-test was applied to analyze NRS values 
regarding NB versus OB (including subgroup analyses for sex 
and study centers). Values are given as mean ± standard devia-
tion (SD). To visualize the distribution of differences in pain 
assessment, including the limits of agreement with upper and 
lower 95% confidence intervals (CIs), we used the method sug-
gested by Bland and Altman:12 for each patient, the difference 
in NRS value between NB and OB was related to the average 
of both NRS values. Linear regression was used to examine a 
possible age dependency of NRS values. Chi-square analysis 
and Fisher’s exact test were applied for frequency analysis of 
the different pain categories in patients who found either OB 
or NB more uncomfortable.
Results
Of the 38 patients eligible for this trial, one patient refused 
participation, one patient died before any biopsies were Journal of Pain Research 2014:7 submit your manuscript | www.dovepress.com
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  conducted, and three patients did not give a pain assessment 
due to organizational reasons. We therefore included 33 
patients (17 females and 16 males) in this trial (five from 
the Ulm group and 28 from the Berlin group). Mean age 
was 63 (±8) years. The mean NRS score for the initial NB 
was 4.5 (±2.7) and for the OB was 3.2 (±2.1) with a statisti-
cally significant difference between both groups (P=0.02) 
(Figure 1A). To examine the clinical relevance of this find-
ing, the differences between NRS in both biopsy techniques 
were evaluated using the Bland–Altman method (Figure 1B). 
Of the patients, 57.6% described the difference as #2 NRS 
points. The plot shows that the majority of people found 
the NB more painful. The limits of agreement for the entire 
cohort ranged between -4.9 and +7.5.
Pain distribution for OB and NB was “mild” in 54.5% 
and 42.4%, “moderate” in 39.4% and 33.3%, and “severe” in 
6.1% and 24.2% of patients (Figure 2A), respectively. When 
comparing these pain categories there was no significant dif-
ference between both biopsy techniques (P=0.12).
All patients were asked to rate which biopsy technique 
was more uncomfortable. NB was chosen by 54.5% of the 
patients as more uncomfortable, 30.3% chose OB, and 15.2% 
found both procedures equally uncomfortable. Next, we con-
ducted a separate analysis of those patients who had described 
one of the biopsy techniques to be more uncomfortable than 
the other. This separate analysis aimed to describe how 
often the difference in NRS (∆NRS) between both biopsy 
techniques was .2. A ∆NRS of 2 had been defined as the 
cutoff for clinically relevant difference in pain (Figure 2B). 
The ∆NRS was .2 in 66.7% of patients rating NB as more 
uncomfortable, compared to 20.0% of patients who had found 
OB more uncomfortable (P=0.02).
Pain assessment was not dependent on age or sex, both 
for raw NRS values and for pain categories. Also, the data 
from both centers were compared to each other, showing 
no significant difference (P=0.13): at both centers mean 
NRS values for the NB were higher than those for the OB. 
Wound healing was regular in all cases, no infections were 
observed.
Discussion
The main results of this trial do not support the general 
assumption that a less invasive muscle biopsy technique 
also causes less intraprocedural pain. When NRS values 
were grouped into mild, moderate, and severe categories, 
both biopsy techniques produced equivalent pain percep-
tion   (Figure 2A). Once raw NRS values were used for pain 
assessment we found that the NB was significantly more 
painful than the OB procedure (Figure 1A). Nevertheless, the 
Bland–Altman analysis showed that the majority of patients 
described the difference in pain perception as equal to or 
less than 2 NRS points (Figure 1B), which from a clinical 
point of view can be interpreted as below the cutoff for a 
clear difference.11
We did find, however, that patients who described the NB 
to be more painful were significantly more likely to quantify 
the difference in pain as clinically relevant with more than 
2 NRS points. In contrast, most patients who found the OB 
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Figure 1 Pain perception during nB and OB.
Notes: (A) Mean nRs values for pain perception during nB and OB in 33 patients. (B) Bland–altman plot comparing differences in nRs values during biopsies. For each 
patient the mean difference in nRs between nB and OB is plotted against the average nRs value of nB and OB. Bold points represent two data points.
Abbreviations: CI, confidence interval; NB, Bergstroem needle biopsy; NRS, numeric rating scale; OB, open surgical biopsy.Journal of Pain Research 2014:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
648
Dengler et al
more uncomfortable described the difference in pain as equal 
to or less than 2 NRS points (Figure 2B). So if patients were 
able to identify one biopsy technique as being more painful, 
this added pain was more likely to be clinically relevant dur-
ing the NB than during the OB.
When planning a muscle biopsy, health care professionals 
are often confronted with a certain anxiety on the patient’s 
part concerning potential pain during the   intervention. The 
patient is interested to know which biopsy technique might 
allow for the least possible amount of discomfort during the 
procedure. Many therapists find it difficult to sufficiently 
inform the patient on this issue and generally assume that 
the less invasive technique might also be less painful. Data 
on pain perception during muscle biopsy procedures, be it 
OB or any type of minimally invasive biopsy, are scarce or 
anecdotal. This prompted us to plan this trial, which is the 
first to present comparative data on NB versus OB.
Dietrichson et al compared pain during muscle biopsy 
with two different minimally invasive techniques: the Liv-
erpool needle, which is similar to the Bergstroem technique, 
and the chonchotome forceps.10 They reported that the con-
chotome was subjectively less painful for the patients, yet no 
objective data on pain were given. Magistris et al evaluated 
pain in patients who underwent muscle biopsy with a spring-
loaded automatic microbiopsy needle device.13 They reported 
that “pain related to the biopsy procedure, when experienced, 
is very brief”. However, no further details were presented. 
Hayot et al compared pain during muscle biopsy with such 
an automatic microbiopsy device versus the Bergstroem NB 
in the same surgical session in 21 patients.11 The automatic 
microbiopsy was conducted first, followed by the NB. They 
stated that pain ranged between 0–1 on the NRS during the 
microbiopsy and between 4–6 during the NB. No more details 
on absolute NRS values or mean values were presented. 
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Figure 2 Pain categories and differences in pain during OB and nB.
Notes: (A) Distribution of categories of intraprocedural pain intensity according to nRs during nB and OB. Pain was categorized as “mild” for nRs 0–3, “moderate” for 
nRs 4–7, and “severe” for nRs 8–10. (B) Patients were grouped into the ones that found nB more uncomfortable (nBmu) and the ones that found OB more uncomfortable 
(OBmu). To visualize potential clinical relevance, the differences in pain perception (∆nRs) were grouped as #2 or .2.
Abbreviations: mu, more uncomfortable; nB, Bergstroem needle biopsy; ∆nRs, difference in nRs values; nRs, numeric rating scale; OB, open surgical biopsy.Journal of Pain Research 2014:7 submit your manuscript | www.dovepress.com
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The only trial giving more detailed information was published 
by Derry et al.14 This trial did not compare NB to another 
technique but did evaluate the level of discomfort in 18 
patients during the Bergstroem NB on a scale from 1 to 10: 
the mean value was 3.9 (±2.9).
Our trial’s mean NRS value of 4.5 for the NB corresponds 
to the pain levels for NB of Hayot et al11 (NRS range 4–6) 
and Derry et al14 (mean NRS 3.9). Hayot et al presented the 
only trial comparing the Bergstroem NB to another technique 
and found a less painful alternative with the spring-loaded 
microbiopsy needle. They described a difference between 
NRS during microbiopsy versus NB of at least 3 NRS points 
in every single patient. We agree that this can be called clini-
cally relevant, especially in contrast to our data, in which 
Bland–Altman analysis revealed that the majority of our 
patients described either no difference or just a rather small 
difference equal to or less than 2 NRS points between the 
NB and the OB (Figure 1B). When interpreting our results as 
indicating clinical equivalence in pain levels during NB and 
OB, one must also conclude that our trial does not support 
the general assumption that a percutaneous biopsy technique 
like the Bergstroem NB is automatically less painful than 
OB techniques.10,11
Our data suggest that OB remains a valid option. It might 
therefore be worth considering some of its   advantages. 
Especially when comparing it to the microbiopsy or the 
Bergstroem NB, OB allows for a larger muscle tissue 
yield, which can even be more easily modified according 
to individual diagnostic needs.15 Another advantage of OB 
is that it requires less profound knowledge of anatomy 
since the muscle tissue is visualized. It is therefore more 
intuitive for young physicians, who are usually the ones 
who conduct muscle biopsy procedures during their first or 
second year of residency. Also, OB requires less coordina-
tive skills than a percutaneous NB. Another disadvantage 
of Bergstroem NB is that it requires the aid of an assistant 
who builds up suction via the 50 mL syringe so that muscle 
tissue gets trapped inside the needle lumen. Coordinating 
this important step during NB takes some practice. Such 
assistance by a second person is not needed during open 
muscle biopsy.
However, one major advantage of the needle technique 
remains unchallengeable: it leaves a significantly smaller 
scar. This is of special relevance when muscle biopsies are 
taken from parts of the body that are not always covered by 
clothes, such as the lower arm or the lower leg. Presumably, 
many patients would accept more pain during a biopsy pro-
cedure if only a smaller scar can be expected. In addition, 
OB carries a higher risk of muscle herniation, hematoma 
formation, or wound dehiscence than NB.16
So if both the Bergstroem needle and the open technique 
are equally available at a given center, we feel that the patient 
should have the opportunity to choose. When informed about 
the extent of invasiveness (eg, larger versus smaller scar) 
and intraoperative pain levels of both procedures, the patient 
will most likely be able to decide between both options. 
  Nevertheless, in our opinion, the results of our trial stress 
that it is important not to insinuate that the Bergstroem NB 
is a less painful alternative to OB.
A strength of our study is that it is the first to directly 
compare pain during the open and the Bergstroem needle 
approach in the same patients. Each patient underwent both 
procedures. This is important, since, if each procedure had 
been carried out in separate groups, one could have argued 
that individual differences in pain perception might have 
served as a bias. Also, the trial showed matching results in 
both participating centers, which reduces the possible influ-
ence the surgeon might have had on pain perception.
Nevertheless, some limitations of this trial need to be 
discussed as well. First of all, our patient cohort exclusively 
comprised amyotrophic lateral sclerosis patients. One might 
argue that pain perception in this specific group of patients 
with varying degrees of degeneration of the central nervous 
system might be different from patients with other diseases, 
eg, myopathies. Also, since the mean age was 63 years, one 
may argue that our results may only be relevant for patients 
of this age group. Furthermore, like Hayot et al, we did not 
randomize the sequence of biopsy types: all patients first 
underwent NB followed by OB.11 The reason for this is that 
the actual study protocol for the trial underlying our pain 
assessment study demanded this exact sequence of biopsies 
since it wanted to rule out any negative influence on histo-
logical readout caused by initially conducting the more trau-
matizing OB. Also, since we exclusively included biopsies 
of deltoid muscles, our results may be limited to this muscle 
group and not generalized to other muscle groups. Another 
limitation is that the distance of 3 cm between both biopsy 
sites may be too small to allow for separate pain quantifica-
tion between both sites. Nevertheless, the distance of 3 cm 
was part of the underlying study protocol and could not be 
changed for this pain study.
Conclusion
The results of this trial suggest that in our patient cohort 
the Bergstroem NB technique did not produce less intrap-
rocedural pain than the OB technique. These findings are Journal of Pain Research
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/journal-of-pain-research-journal
The Journal of Pain Research is an international, peer-reviewed, open 
access, online journal that welcomes laboratory and clinical findings 
in the fields of pain research and the prevention and management 
of pain. Original research, reviews, symposium reports, hypothesis 
formation and commentaries are all considered for publication.   
The manuscript management system is completely online and 
includes a very quick and fair peer-review system, which is all easy 
to use. Visit http://www.dovepress.com/testimonials.php to read real 
quotes from published authors.
Journal of Pain Research 2014:7 submit your manuscript | www.dovepress.com
Dovepress 
Dovepress
Dovepress
650
Dengler et al
relevant since they contradict the general assumption that 
a less invasive muscle biopsy technique might also be less 
painful. We therefore feel that when informing the patient 
about advantages and disadvantages of both biopsy tech-
niques, the amount of intraprocedural pain should not serve 
as a differentiating characteristic.
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